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The proteasome is a protein-
degrading molecular complex that is 
necessary for protein homeostasis and various 
biological functions, including cell cycle 
regulation, signal transduction, and immune 
response. Proteasome activity is finely 
regulated by a variety of proteasome-
interacting molecules. PITHD1 is a recently 
described molecule that has a domain 
putatively capable of interacting with the 
proteasome. However, it is unknown as to 
whether PITHD1 can actually bind to 
proteasomes and what it does in vivo. Here we 
report that PITHD1 is detected specifically in 
the spermatids in the testis and the cortical 
thymic epithelium in the thymus. Interestingly, 
PITHD1 associates with immunoproteasomes 
in the testis, but not with thymoproteasomes in 
the thymus. Mice deficient in PITHD1 exhibit 
severe male infertility accompanied with 
morphological abnormalities and impaired 
motility of spermatozoa. Furthermore, 
PITHD1 deficiency reduces proteasome 
activity in the testis and alters the amount of 
proteins that are important for fertilization 
capability by the sperm. However, the 
PITHD1-deficient mice demonstrate no 
detectable defects in the thymus, including T 
cell development. Collectively, our results 
identify PITHD1 as a proteasome-interacting 
protein that plays a nonredundant role in the 
male reproductive system. 
 
Introduction 
        Protein degradation is a crucial 
process in cellular homeostasis. The 
proteasome is a large enzyme complex 
responsible for protein degradation in cells (1). 
In most cases, proteasome-dependent 
proteolysis targets ubiquitinated proteins (2, 
3). Protein degradation by the proteasome is 
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important for not only the maintenance of 
protein homeostasis, but also various 
biological functions, including cell cycle 
regulation, signal transduction, and immune 
response (3, 4). The proteasome consists of a 
20S catalytic core proteasome and regulatory 
particles that bind to the core proteasome (5). 
The 20S proteasome is composed of 28 
subunits, namely, 2 sets of 7 different a 
subunits (a1–a7) and 7 different b subunits 
(b1–b7). Among the 20S proteasome 
components, b1, b2, and b5 have catalytic 
activities (6). The proteasome containing b1, 
b2, and b5 is called the constitutive 
proteasome and expressed in most tissues. On 
the other hand, antigen-presenting immune 
cells, hematopoietic cells, and cells exposed to 
proinflammatory cytokines express the 
immunoproteasome in which b1i, b2i, and b5i 
are incorporated in place of b1, b2, and b5, 
respectively (7). Immunoproteasomes possess 
altered proteolytic activity and participate in 
the efficient processing of MHC class I-
restricted antigens (8). In the thymus, another 
catalytic subunit b5t is specifically expressed 
in cortical thymic epithelial cells (cTECs) and 
incorporated into the 20S proteasome together 
with b1i and b2i, thereby forming the 
thymoproteasome (9, 10). Thymoproteasomes 
in cTECs are essential for the production of 
self-antigens that induce the positive selection 
of CD8+ T cells (9, 11). Thymoproteasome-
dependent positive selection in the thymus 
also fine-tunes antigen responsiveness of 
CD8+ T cells in the periphery (12). 
The function of the 20S proteasome 
is modulated by interactions with regulatory 
proteins. A wide variety of proteasome-
interacting proteins have been identified, the 
most well-known of which is the 19S 
regulatory particle that binds to both ends of 
the 20S proteasome to form the 26S 
proteasome complex (10, 13, 14). The 19S 
regulatory particle consists of 6 ATPase 
subunits and 13 non-ATPase subunits, and 
pre-processes substrates for degradation by 
the 20S proteasome. Furthermore, ubiquitin 
chain binding receptors, de-ubiquitinating 
enzymes, and E3 ubiquitin ligases associate 
with the 19S regulatory particle, and assist or 
modulate proteasomal functions (13, 15). In 
addition to the 19S regulatory particle, 
proteasome activators and inhibitors, such as 
PA200, PA28, and PI31, directly bind to the 
20S proteasome (13-16).     
In the course of our explorative 
study for thymoproteasome modulators in 
cTECs, we noticed that a functionally 
unidentified gene encoding PITHD1 was 
abundantly expressed in cTECs. PITHD1 has 
a putative proteasome-interacting thioredoxin 
(PITH) domain that potentially binds to the 
proteasome. Another PITH domain-
containing protein, thioredoxin-like protein 1 
(TXNL1), possesses redox activity (17). 
Unlike TXNL1, PITHD1 lacks redox activity 
due to the absence of the active-site motif of 
thioredoxin (18). It has been reported that the 
ectopic expression of PITHD1 in human 
leukemia cell lines promotes megakaryocyte 
development by regulating the expression of 
RUNX1, a transcription factor that is 
important for lineage determination between 
megakaryocytes and erythrocytes in 
hematopoiesis (18, 19). However, whether 
PITHD1 can actually bind to proteasomes and 
what it does in vivo are not known. We report 
herein that PITHD1 is highly expressed in 
cTECs and the testis. PITHD1 associates with 
immunoproteasomes in the testis, but not with 
thymoproteasomes in cTECs. By producing 
mice deficient in PITHD1, we show that 
PITHD1 deficiency causes infertility 
accompanied with morphological 
abnormalities and impaired motility of 
spermatozoa, without detectable defects in the 
development and function of cTECs. We 
further show that PITHD1 deficiency reduces 
proteasome activity in the testis and alters the 
amount of several proteins that are important 
for fertilization capability by the sperm. Our 
study reveals a novel and nonredundant 
function of PITHD1 as a proteasome-




Detection of PITHD1 in cTECs and testis 
We have previously reported that 
the b5t-containing thymoproteasome 


























for the positive selection of CD8+ T cells in 
the thymus (9-12). Accordingly, we explored 
proteasome-interacting proteins that could 
affect the function of thymoproteasomes in 
cTECs. We found that Pithd1, which encodes 
PITHD1 that contains a putative proteasome-
interacting domain, was highly expressed in 
cTECs in the transcriptomic profiles of thymic 
epithelial cells (20). Quantitative RT-PCR 
analysis confirmed that the expression of 
Pithd1 was higher in cTECs than other thymic 
cells, including medullary thymic epithelial 
cells (mTECs), CD45+ thymocytes, and non-
TEC stroma cells (Fig. 1A). Moreover, we 
detected a significantly higher expression of 
Pithd1 in the testis than other organs (Fig. 1A). 
Thus, we found that Pithd1 is specifically and 
abundantly expressed in cTECs and the testis.  
The detected PCR products of 
Pithd1 were 328 bp in size, derived from 
spliced RNA, and not 9558 bp from genomic 
DNA (Fig. S1A). PCR detection of Hprt 
reconfirmed that the amplified signals in our 
RT-PCR analysis were primarily 249 bp 
derived from spliced RNAs and not 1087 bp 
derived from genomic DNAs contaminated in 
the total RNA samples (Fig. S1A).  
 
PITHD1 associates with immunoproteasomes 
in testis but not with thymoproteasomes in 
cTECs 
We next examined the association 
capability of PITHD1 proteins with 
proteasomes in cTECs and the testis. 
Immunoprecipitation of mouse thymus lysates 
using antibody specific for the cTEC-specific 
thymoproteasome component b5t showed that 
PITHD1 protein was absent from the 
precipitates (Fig. 1B). This was not due to the 
failure of immunoprecipitation by anti-b5t 
antibody because in addition to b5t protein, 
a6 protein, which is a 20S proteasome 
component, was immunoprecipitated by this 
antibody (Fig. 1B). Similarly, PITHD1 
protein in the thymus was not 
immunoprecipitated by anti-a6 antibody, 
whereas b5t protein was co-precipitated by the 
same anti-a6 antibody (Fig. 1C and Fig. S1B). 
In the testis, the expression of 
immunoproteasomes and testis-specific 
proteasomes has been reported (21-23). In the 
testis-specific proteasome, the a4s subunit is 
incorporated into the constitutive proteasome 
in place of the a4 subunit (21). 
Immunoprecipitation of testis lysates using 
antibody specific for a4s showed the absence 
of PITHD1 protein in the precipitates (Fig. 
1D). Again, this was not due to the failure of 
immunoprecipitation by anti-a4s antibody, 
because in addition to a4s protein, a6 protein 
was immunoprecipitated by this antibody (Fig. 
1D). On the contrary, immunoprecipitation by 
anti-b5i antibody or anti-a6 antibody revealed 
the presence of PITHD1 protein in the 
precipitates (Fig. 1, E and F). Therefore, these 
results indicate that PITHD1 associates with 
b5i-containing immunoproteasomes in the 
testis either directly or indirectly, whereas it is 
incapable of binding to a4s-containing testis-
specific proteasomes in the testis or b5t-
containing cTEC-specific thymoproteasomes 
in the thymus. 
In b5t-deficient cTECs, b5i is 
compensatively expressed, thereby forming 
immunoproteasomes instead of 
thymoproteasomes (11). Therefore, we 
examined whether PITHD1 could associate 
with immunoproteasomes in b5t-deficient 
cTECs or b5t-sufficient cTECs. We found that 
immunoprecipitation of b5t-deficient thymus 
lysates using antibody specific for b5i showed 
that PITHD1 protein was absent from the 
precipitates (Fig. 1, G and H). These results 
indicate that PITHD1 is incapable of binding 
to thymoproteasomes or immunoproteasomes 
expressed in cTECs. 
 
Generation of PITHD1-deficient mice 
To investigate the physiological 
role of PITHD1, we next generated PITHD1-
deficient mice by introducing a targeting 
vector that contained a gene encoding the 
tandem dimeric tomato fluorescent protein 
(tdTomato) at the translation initiation site in 
exon 1 of the Pithd1 gene along with 
neighboring genomic sequences into HK3i 
embryonic stem cells for homologous 
recombination (Fig. 2A). Thus, the tdTomato 
fluorescent protein would be detectable in the 
cells where Pithd1 was transcribed in this 
mouse. PCR analysis, Southern blot analysis, 


























isolated from the offspring mice indicated 
successful germline recombination at the 
Pithd1 locus (Fig. 2, B and C). Quantitative 
RT-PCR analysis showed that Pithd1 mRNA 
expression in the thymus and the testis was 
lost in PITHD1-/- mice (Fig. 2D). 
Immunoblot analysis also confirmed the loss 
of PITHD1 protein in the thymus and the testis 
in PITHD1-/- mice (Fig. 2E). The tdTomato 
fluorescent protein was detectable in the 
Ly51-expressing cortical region of the 
PITHD1+/- thymus (Fig. 2F). Flow 
cytometric analysis of thymic cells showed 
tdTomato expression in approximately 3% of 
cTECs (Fig. 2G), suggesting that PITHD1 is 
expressed in a minor subpopulation of cTECs. 
Intense tdTomato fluorescence was detected 
in the testicular regions surrounding the lumen 
of seminiferous tubules (Fig. 2H). Flow 
cytometric analysis showed that 37% of 
testicular cells highly expressed the tdTomato 
fluorescent protein (Fig. 2I). Microscopic 
inspection of testicular cells revealed that the 
tdTomato fluorescence was detectable in the 
cytoplasm of elongated spermatids, whereas it 
was not detected in round spermatids or other 
testicular cells (Fig. 2J). The tdTomato 
fluorescence was also detectable in the 
cytoplasmic droplets of sperm where proteins 
are transiently stored and eventually removed 
in mature sperm (Fig. 2J). We obtained two 
independent mouse lines exhibiting an 
identical phenotype, and will show the results 
from one PITHD1-/- mouse line in this report.   
 
No abnormalities in development and function 
of cTECs in PITHD1-deficient mice 
We then examined the impact of 
PITHD1 deficiency in the thymus. 
Hematoxylin and eosin staining and 
immunofluorescence analysis of the thymic 
sections showed unaffected corticomedullary 
architectures in PITHD1-/- mice (Fig. 3, A 
and B). Similar to the wild-type thymus, the 
cortical regions of PITHD1-/- mice were 
enriched with b5t+ cTECs and the PITHD1-/- 
thymic medullas contained Aire+ mTECs 
essential for the generation of self-tolerant T 
cells (Fig. 3B). Flow cytometric analysis of 
liberase-digested thymic cells showed that the 
cellularity of CD45-EpCAM+UEA1-Ly51+ 
cTECs and CD45-EpCAM+UEA1+Ly51- 
mTECs, and their proteasome activity were 
undisturbed in PITHD1-/- mice (Fig. 3, C and 
D). Furthermore, neither the development nor 
the cellularity of thymocytes, including 
CD4/CD8 subpopulations and CD25/CD44 
CD4-CD8- double negative (DN) 
subpopulations, was altered by PITHD1 
deficiency (Fig. 3, E and F). The development 
of CD4+CD8+ double positive (DP) 
thymocytes has been subdivided into three 
subpopulations: CD69-TCRb-/low pre-
selected DP cells (population I), 
CD69+TCRblow post-selected DP cells 
(population II), and CD69+TCRbhigh post-
selected DP cells (population III) (24). The 
cellularity of DP thymocytes in each 
subpopulation was comparable between wild-
type mice and PITHD1-/- mice (Fig. 3G). 
Consistent with the normal thymocyte 
development in PITHD1-/- thymus, the 
cellularity of splenic CD4+ T cells and CD8+ 
T cells was comparable to those in wild-type 
mice (Fig. 3H). Therefore, these results 
indicate that despite the physiological 
expression of PITHD1 in cTECs, PITHD1 
deficiency has no detectable impact on the 
development and function of the thymus.   
We also examined whether PITHD 
deficiency induces the phenotypic alteration 
of the thymus in b5t-/- mice. The cellularity of 
cTECs and mTECs in b5t-/- mice was not 
altered by PITHD1 deficiency (Fig. 4A). 
Furthermore, the cellularity of TCRbhigh 
CD4-CD8+ thymocytes and splenic CD8+ T 
cells, which was reduced in b5t-/- mice, was 
neither further decreased nor recovered by 
PITHD1 deficiency (Fig. 4, B and C). Taken 
together with the finding that PITHD1 is 
incapable of binding to thymoproteasomes in 
b5t-sufficient cTECs or immunoproteasomes 
in b5t-deficient cTECs, these results indicate 
that PITHD1 plays no apparent roles in the 
thymus in the presence or absence of the 
thymoproteasome. 
 


























We then examined the functional 
significance of PITHD1 in the testis. The 
weights of the testis and the epididymis were 
comparable between PITHD1+/- and 
PITHD1-/- mice (Fig. 5A). The morphology 
of the testis and the epididymis was 
undisturbed by PITHD1 deficiency (Fig. 5B). 
However, when PITHD1-/- male mice were 
mated with C57BL/6 female mice for 2 
months, no pregnancy was observed in female 
mice even though vaginal plug formation was 
detectable (Fig. 5C). On the other hand, 
PITHD1+/- male mice were able to 
impregnate female mice and 7 pups were 
produced on average per pregnancy (Fig. 5C). 
An in vitro fertilization assay confirmed the 
fertilization incapability of sperm isolated 
from PITHD1-/- mice in both cumulus-intact 
condition and cumulus-free condition (Fig. 
5D). However, PITHD1-/- sperm were able to 
fertilize an egg under the zona-pellucida-free 
condition (Fig. 5D). Therefore, these results 
indicate that sperm from PITHD1-/- mice are 
defective in fertilization capability due to 
passage disability through egg layers such as 
cumulus and zona pellucida. We noticed no 
defects in the fertility of female PITHD1-/- 
mice (data not shown). 
 
PITHD1-deletion mice exhibit similar 
phenotype to PITHD1-deficient mice 
The results so far indicated that 
PITHD1 is important for male reproductive 
function rather than cTEC function. However, 
it remained possible that the artificial 
expression of tdTomato in PITHD1-/- mice 
might have hindered the phenotypes that could 
have resulted simply from the loss of PITHD1. 
Therefore, we next generated a new set of 
PITHD1-deletion mice (D/D) in that the 
genomic region spanning the middle of exon 
1 to exon 3 was deleted by CRISPR/Cas9 
technology (Fig. 6A). PCR analysis of 
genomic DNA isolated from the offspring 
mice indicated successful deletion of Pithd1 
genomic sequence (Fig. 6B). Quantitative RT-
PCR analysis and immunoblot analysis 
confirmed the loss of PITHD1 at mRNA and 
protein levels (Fig. 6, C and D). Like 
PITHD1-/- mice, the cellularity of Ly51+ 
cTECs and UEA1+ mTECs as well as those of 
thymocyte subpopulations and splenic T cells 
was undisturbed in PITHD1D/D mice (Fig. 6, 
E-G). The morphology of the testis and the 
epididymis was also undisturbed in 
PITHD1D/D mice (Fig. 6H). However, in vitro 
fertilization assay of sperm isolated from 
PITHD1D/D mice revealed fertilization 
incapability in both cumulus-intact condition 
and cumulus-free condition, like PITHD1-/- 
mice and unlike PITHD1WT/D mice (Fig. 6I). 
Therefore, these results indicate that the 
aberrant expression of the tdTomato 
fluorescent protein has essentially no impact 
on the phenotype of PITHD1-/- mice, and 
reinforce that the impaired fertilization 
capability of sperm is caused by PITHD1 
deficiency.           
 
PITHD1 deficiency results in abnormal 
morphology and impaired motility of sperm 
To understand the mechanism 
behind male infertility caused by PITHD1 
deficiency, we next examined the morphology 
of mature sperm isolated from the cauda 
epididymis of PITHD1-/- mice (Fig. 7A). The 
number of sperm was comparable between 
PITHD1+/- mice and PITHD1-/- mice (data 
not shown). However, the frequency of sperm 
with normal morphology was significantly 
reduced in PITHD1-/- mice compared to 
PITHD1+/- mice (Fig. 7B). On the other hand, 
the frequency of sperm with multi heads was 
significantly increased in PITHD1-/- mice 
(Fig. 7B). The reduction of morphologically 
normal sperm and the increase of sperm with 
abnormal midpiece and multi heads were also 
detected in PITHD1D/D mice (Fig. 7C). We 
next examined the motility of sperm incubated 
in TYH medium for 10 min or 2 h by 
measuring the average path velocity (VAP), 
the curvilinear velocity (VCL), and the 
straight-line velocity (VSL). The values of 
these motility parameters for PITHD1-/- 
sperm were comparable to those for 


























(Fig. 7D). However, a significant reduction of 
these velocities was detected in PITHD1-/- 
sperm after 2 h incubation (Fig. 7D). Similarly, 
motility reduction in PITHD1D/D sperm was 
detected after 2 h incubation (Fig. 7E). 
Morphological analysis revealed that motile 
sperm from PITHD1+/- and PITHD1WT/D 
mice were predominantly morphologically 
normal, whereas a majority of motile sperm 
from PITHD1-/- and PITHD1D/D mice 
exhibited morphological abnormalities (Fig. 7, 
F and G). Collectively, these results indicate 
that PITHD1 deficiency causes impaired 
sperm motility accompanied with 
morphological abnormalities.   
 
PITHD1 regulates proteasome activity in 
testicular cells 
So far, we have shown that PITHD1 
associates with b5i-containing 
immunoproteasomes in the testis and that its 
deficiency causes impaired sperm motility. 
We therefore speculated the possibility that 
PITHD1 deficiency might affect proteasome 
activity in the testis. In mice that carried the 
Pithd1-knock-out tdTomato-knock-in allele 
(Fig. 2A), tdTomato fluorescence expression 
enabled the detection of cells in that Pithd1 
was transcribed. In the testis of these mice, 
tdTomato fluorescence was detected in the 
elongated spermatids and the cytoplasmic 
droplets of sperm (Fig. 2J). We examined 
proteasome activity in tdTomato+ and 
tdTomato- cells in the testis by using a cell-
permeable triple-leucine substrate-based 
fluorescent probe that shows high affinity 
binding to the chymotrypsin-like catalytic site 
of proteasomes (25). The fluorescence 
intensity detected with this probe could reflect 
the chymotrypsin-like activity and/or the 
abundance of proteasomes. We found that the 
fluorescence intensity in tdTomato+ testicular 
cells was significantly reduced in PITHD1-/- 
mice compared to PITHD1+/- mice (Fig. 8, A 
and B, and Fig. S2A). We also found that the 
fluorescence intensity was unaltered in 
tdTomato- testicular cells, tdTomato+ sperm, 
and tdTomato- sperm by PITHD1 deficiency 
(Fig. 8, A and B). It was possible that the 
reduced proteasome activity was due to the 
reduced abundance of proteasomes. Indeed, 
the amount of the immunoproteasome 
component b5i in tdTomato+ testicular cells 
was significantly reduced in PITHD1-/- mice 
compared to that in PITHD1+/- mice (Fig. 
S2B). We also found that the proteasome 
activity measured by the fluorescent probe 
was higher in tdTomato+ testicular cells than 
tdTomato- testicular cells, and subsequently 
reduced in tdTomato+ sperm and tdTomato- 
sperm in both PITHD1+/- mice and PITHD1-
/- mice (Fig. 8, A and B). Correlated with the 
higher proteasome activity in tdTomato+ 
testicular cells than sperm, immunoblot 
analysis using lysate from PITHD1+/+ cells 
showed that the amount of PITHD1 protein 
was high in the testis but reduced in caput 
epididymal sperm and cauda epididymal 
sperm (Fig. 8C). Taken together, these results 
indicate that PITHD1 regulates proteasome 
activity including its abundance in testicular 
cells including elongated spermatids.   
We finally performed mass-
spectrometry-based quantitative proteomic 
analysis of sperm isolated from PITHD1+/+ 
mice and PITHD1-/- mice. Proteins extracted 
from sperm were digested with trypsin, and 
the peptides were labeled with isobaric 
tandem mass tag (TMT) reagents. A high 
confidence analysis at 1% false discovery rate 
(FDR) of liquid chromatography-tandem 
mass spectrometric (LC-MS/MS) profiles 
resulted in the identification and 
quantification of 3,727 protein species (Table 
S1). Although few proteins showed 
significant alteration in abundance (Q < 0.05) 
in the comparison between PITHD1+/+ mice 
and PITHD1-/- mice, modest differences (Q < 
0.15) in the amounts of several proteins were 
detected (Fig. 8D). Only one protein MROH7 
showed significantly (Q < 0.15) higher 
expression in sperm from PITHD1-/- mice 
than PITHD1+/+ mice, but its role in sperm is 
unknown (Fig. 8D). On the contrary, seven 
protein species were detected at significantly 


























PITHD1-/- mice than PITHD1+/+ mice (Fig. 
8D). Among these seven proteins, ACE, 
PRKAR1A, and TEX101 are known to be 
important for the fertilization capability of 
sperm (26-29). The other four proteins 
(RPS27A, PRSS39, and the 19S proteasomal 
regulatory subunits PSMC2 and PSMD1) 
were also implicated in sperm function (30-
34). Therefore, these results suggest that the 
PITHD1-mediated regulation of proteasomes 
in elongated spermatids is required for the 
quantitative control of proteins important for 




The present results demonstrate that 
PITHD1, which is highly expressed in cTECs 
and the testis, associates with the 
immunoproteasomes in the testis, but not with 
a4s-containing testis-specific proteasomes or 
cTEC-specific thymoproteasomes. The 
present results also demonstrate that mice 
specifically deficient in PITHD1 show male 
infertility accompanied with morphological 
abnormalities and impaired motility of sperm. 
PITHD1 deficiency results in the reduction of 
proteasome activity and/or abundance in 
testicular cells including elongated spermatids 
and the alteration in the amount of proteins 
important for fertilization capability in sperm. 
Thus, this study reveals that PITHD1 is a 
proteasome-interacting protein that plays a 
nonredundant role in the male reproductive 
system. 
Our proteomic analysis of sperm 
shows that the amounts of 7 proteins (ACE, 
PRKAR1A, RPS27A, TEX101, PRSS39, 
PSMC2, and PSMD1), which have all been 
implicated in male fertilization capability, are 
reduced by PITHD1 deficiency. It was 
previously reported that mice deficient in 
ACE and its specific substrate TEX101 
exhibit male infertility due to the impaired 
ability of sperm to migrate into the oviduct 
(26-28). The haploinsufficiency of 
PRKAR1A was reported to cause the fertility 
defects accompanied with morphological 
abnormalities of sperm in both mouse and 
human (29). The association between male 
infertility and the reduced expression of 
RPS27A and the 19S regulatory subunit 
PSMC2 was shown in transcriptomic and 
proteomic analyses of human sperm (30, 31, 
33). It was also suggested that PRSS39 and the 
19S regulatory subunit PSMD1 play a role in 
zona penetration by sperm (32, 34). In this 
study, we demonstrated that the reduction of 
proteasome activity and/or abundance by 
PITHD1 deficiency is detectable in testicular 
cells including elongated spermatids, rather 
than sperm. It is therefore conceivable that the 
regulation of proteasomes by PITHD1 in 
testicular cells is important for the optimal 
expression of these 7 proteins in mature sperm.  
Our results show that the reduction 
of proteasome activity and/or abundance in 
testicular cells is modest in PITHD1-deficient 
mice. It was recently reported that mice 
deficient in a4s, a component of testis-
specific proteasome, exhibit infertility in male, 
and proteins that are normally degraded 
during spermatogenesis are accumulated in 
testicular cells in a4s-deficient mice, although 
the reduction of proteasome activity is also 
mild in the testis of these mice (22, 23). It was 
also reported that proteasome activity per se is 
not reduced in b5t-deficient cTECs, although 
b5t deficiency markedly impairs the positive 
selection of CD8+ T cells in the thymus (9-11, 
20). Therefore, the modest reduction of 
proteasome activity and/or abundance in 
testicular cells by PITHD1 deficiency may 
sufficiently affect the function of key proteins 
that are important for fertilization capability. 
Our immunoprecipitation 
experiments reveal that PITHD1 associates 
with immunoproteasomes in the testis but not 
with immunoproteasomes or 
thymoproteasomes in the thymus. It was 
previously demonstrated that the proteasome 
activator PA200 is highly expressed in the 
testis, and approximately 90% of proteasomes 
in the testis contain PA200 at either one or 
both ends of the 20S proteasomes (35, 36). On 
the contrary, in our recently published 
proteomic profiles, PA200 was undetectable 
in cTECs (20). Therefore, PA200 expression 
in the testis may support the association of 
PITHD1 with immunoproteasomes in the 
testis but not in cTECs. Our results also show 


























containing testis-specific proteasomes. It was 
previously reported that the a4s subunit is 
highly expressed in spermatocytes and 
spermatids, and the a4s-containing testis-
specific proteasomes contain PA200 (21-23, 
36). However, a4s is incorporated into the 
constitutive proteasomes and not the 
immunoproteasomes (21). It is possible that 
the type of 20S proteasomes, in addition to the 
association with other proteasome-interacting 
proteins, is important for the association of 
PITHD1 with proteasomes. 
The role of proteasome-interacting 
proteins, including PA200 and PA28g, in the 
male reproductive system was studied 
previously. PA200 is essential for the 
acetylation-associated degradation of core 
histones to replace histones with protamines in 
elongated spermatids, and that is a necessary 
chromatin remodeling that gives rise to 
healthy sperm (36). Indeed, mice deficient in 
PA200 exhibit male subfertility accompanied 
with the reduced production of healthy sperm 
(37). It was also reported that PA28g-deficient 
male mice are subfertile due to the reduced 
production and motility of sperm (38, 39). 
Furthermore, PA200/PA28g double 
deficiency causes infertility with defect in 
sperm motility (40). Therefore, it is possible 
that PITHD1 functions in the male 
reproductive system coordinately with other 
proteasome-interacting proteins, including 
PA200 and PA28g.  
We further show that the impaired 
motility and the morphological abnormalities 
of sperm are caused by PITHD1 deficiency. 
The morphological abnormalities of sperm 
from PITHD1-deficient mice could be the 
cause of the defect in sperm motility. However, 
approximately 50% of sperm showed normal 
morphology in PITHD1-deficient mice under 
macroscopic observation. The motility of 
sperm is generated by axoneme in flagellum, 
which consists of two central microtubules 
surrounded by nine pairs of microtubules (41). 
Therefore, morphologically normal sperm in 
PITHD1-deficient mice may indeed have a 
defect in the ultrastructure of flagellum, 
including microtubules, which is undetectable 
under macroscopic observation.  
Finally, our results show that 
PITHD1-tdTomato protein is detected in 
approximately 3% of cTECs. In the thymus, 
both cTECs and mTECs consist of diverse 
subpopulations, and cTECs are heterogeneous 
in the expression of functionally important 
molecules, including interleukin-7, delta-like-
4, and MHC class II (42). The heterogeneity 
of cTECs in PITHD1-tdTomato expression 
newly detected in this study offers an 
additional diversity in cTECs. Our results also 
show that PITHD1-deficient mice exhibit no 
apparent defects in the thymus, including the 
development of TECs and thymocytes. Our 
results further denote that the impaired 
generation of TCRbhigh CD4-CD8+ 
thymocytes in b5t-deficient thymus is neither 
further decreased nor recovered by PITHD1 
deficiency. These results indicate that 
PITHD1 plays no apparent roles in the thymus 
in the presence or absence of the 
thymoproteasome. However, it is still possible 
that PITHD1 in the thymus plays a presently 
unknown role mediated by a minor 
subpopulation of cTECs.     
        In conclusion, the present study 
reveals the nonredundant function of the 
testis-specific proteasome-interacting protein 
PITHD1 in the male reproductive system in 
mouse. PITHD1 protein has been detected in 
the human testis (The Human Protein Atlas 
public database). Although the association 
between PITHD1 and infertility has not been 
reported in genome-wide association studies, 
PITHD1 could actually be an additional 
molecule important in human male fertility. 
Our findings may provide clues to better 
understand the molecular mechanisms in the 
male reproductive system common to mouse 
and human.       
 
Experimental procedures  
 
Mouse 
        C57BL/6 mice, B6D2F1 mice, and 
ICR mice were obtained from SLC. b5t-
deficient mice were described previously (9). 
All mouse experiments were performed with 
consent from the Animal Experimentation 
Committee of Tokushima University (T28-


























Committee of the Research Institute for 
Microbial Diseases, Osaka University (H28-
08, H30-01), and from the Institutional 
Animal Care and Use Committee (IACUC) of 
RIKEN Kobe Branch (A2001-03). 
 
Generation of PITHD1-deficient mice 
        The targeting vector shown in Fig. 2 
was prepared by subcloning PITHD1-
containing mouse genomic DNA and 
tdTomato-encoding cDNA (Clontech) into a 
plasmid containing a pgk-neo cassette. The 
linearized targeting vector was introduced into 
HK3i ES cells from C57BL/6N embryos (43). 
Targeted alleles were screened by genomic 
PCR analysis and Southern blot analysis. 
PITHD1- mice (PITHD1tm1(tdTomato), 
accession no. 
CDB1274K, http://www2.clst.riken.jp/arg/m
utant%20mice%20list.html) are available to 
the scientific community. The primers used 







Generation of PITHD1-deletion mice  
As shown in Fig. 6A, guide RNAs 
which recognize sequences in the exon 1 (5’- 
GCTGTACCTGCGCATCGACC-3) or exon 
3 (5’- ACTCACAGTCTCATCTCCGA-3’) 
were designed using CRISPRdirect web tool 
(crispr.dbcls.jp). Their cleavage activity was 
validated by single-strand annealing (SSA) 
assay (44). Wild-type zygotes were obtained 
by mating superovulated B6D2F1 females 
with B6D2F1 males. The two gRNA/Cas9 
complexes were electroporated into two 
pronuclear zygotes using a super 
electroporator NEPA21 (NEPA GENE, Chiba, 
Japan) (45). The zygotes were cultivated in 
KSOM medium overnight, and the developed 
two-cell-stage embryos were transferred into 
the oviducts of pseudopregnant ICR females. 
The F0 pups obtained were genotyped by PCR 
using primer 1 and 2 for detecting wild-type 
allele or primer 1 and 3 for detecting knockout 
allele. The DNA sequence of the mutant 
alleles (PITHD1D or PITHD1em1) was 
further confirmed by Sanger sequencing. The 
crRNA target sequences and primers for 




3, 5’- TAGGTGGGAGTCTCCCGAGG-3’. 
 
Southern blot analysis 
Genomic DNA extracted from the 
liver was digested with BamHI, 
electrophoresed in 1% agarose, and 
transferred to nylon membrane (Hybond-N+, 
GE Healthcare). Probes were labeled with a 
PCR DIG Probe Synthesis Kit (Roche), and 
hybridization was detected using anti-DIG-
AP Fab fragment (Roche), CDP-STAR 
(Roche), and Light Capture II (Atto). The 
primers used for Southern blot analysis were 




Quantitative RT-PCR analysis 
        Total cellular RNA was reverse-
transcribed (RT) with PrimeScript Reverse 
Transcriptase (TaKaRa). Quantitative real-
time polymerase chain reaction (PCR) was 
performed using SYBR Premix Ex Taq 
(TaKaRa) and a StepOnePlus Real-Time PCR 
System or a 7900HT Sequence Detection 
System (Applied Biosystems). The primers 
used were as follows: Pithd1, 5’-






Amplified products were confirmed to be 
single bands in gel electrophoresis and 




Thymic cells were isolated from 
newborn mice. Testicular cells were isolated 
from 6-week-old mice. The cells were lysed in 
ice-cold lysis buffer containing 0.2% NP-40, 
25 mM Tris-HCl (pH 7.5), 1 mM 


























and clarified by centrifugation at 20,000 × g 
for 15 min at 4 °C. For immunoprecipitation, 
anti-b5t antibody (MBL International) (20), 
anti-b5i antibody (Proteintech) (46), anti-a4s 
antibody (Proteintech) (22), or anti-a6 
antibody (Bethyl Laboratories) was bound to 
Protein G-Sepharose beads (GE Healthcare) 
and mixed with the cell lysates at 4 °C for 2 
hours. The beads were washed with lysis 
buffer, and immunoprecipitated molecules 
were eluted with 2 x SDS sample buffer 
containing 125 mM Tris-HCl (pH 6.5), 4% 
SDS, 20% glycerol, 0.2 M dithiothreitol, and 
0.01% bromophenol blue. 
 
Immunoblot analysis 
The immunoprecipitated molecules 
or the cell lysates were boiled with SDS 
sample buffer, separated by SDS-PAGE, and 
transferred to a polyvinylidene difluoride 
membrane. Membranes were probed with 
anti-PITHD1 antibody (Sigma Aldrich), anti-
 b5t antibody (MBL International) (20), anti-
b5i antibody (Proteintech) (46), anti-a4s 
antibody (Proteintech) (22), anti-a6 antibody 
(Bethyl Laboratories), or anti-b-actin 
antibody (Cell Signaling Technology) (47), 
and then with secondary antibodies 
conjugated to horseradish peroxidase (Santa 
Cruz). Signals were detected with ECL 
reagent (GE Healthcare) and Image analysis 
system (Atto). 
 
Flow cytometric analysis 
        For the analysis of thymic epithelial 
cells (TECs), minced thymuses were digested 
with 0.5 unit/mL Liberase (Roche) in the 
presence of 0.02% DNase I (Roche). Single-
cell suspensions were stained with antibodies 
specific for EpCAM (CD326, BioLegend, 
clone G8.8), CD45 (BioLegend, clone 30-
F11), and Ly51 (CD249, BioLegend, clone 
6C3), and for the reactivity with UEA1 
(Vector Laboratories). For the analysis of 
thymocytes and spleen cells, cells were 
stained with antibodies specific for CD3 
(BioLegend, clone 145-2C11), CD4 
(BioLegend, clone RM4-5), CD8a 
(Invitrogen, clone 5H10), TCRb (BioLegend, 
clone H57), CD25 (BioLegend, clone PC61), 
CD44 (eBioscience, clone IM7), and CD69 
(eBioscience, clone H1.2F3). Multicolor flow 
cytometry was performed on FACSVerse. 
 
Proteasome activity assay 
Surface-stained thymus cells, 
testicular cells, and sperm were incubated 
with 1 µM cell-permeable triple-leucine 
substrate-based fluorescent probe 
(Me4BodipyFL-Ahx3Leu3 VS, Boston 
Biochem), which shows high affinity binding 
to the chymotrypsin-like catalytic site of 
proteasomes, at 37 °C for 60 min, and then 
washed with FACS buffer. Where indicated, 
the cells were incubated at 37 oC for 1 hour in 
the presence of the proteasome inhibitor 
MG132 (AdooQ Bioscience) prior to the 
incubation with the proteasome activity probe. 




        Frozen thymuses, testis, and 
epididymis embedded in OCT compound 
(Sakura Finetek) were sliced into 10-µm-thick 
sections. Tissue sections stained with 
hematoxylin and eosin were examined under a 
light microscope. For immunofluorescence 
analysis, the thymuses and the testis were 
fixed in 4% (g/vol) paraformaldehyde and 
embedded in OCT compound. Frozen tissues 
were sliced into 10-µm-thick sections. The 
thymic sections were stained with anti-b5t 
antibody, anti-Ly51 antibody, anti-Aire 
antibody, and UEA-1, followed by 
AlexaFluor-conjugated secondary reagents. 
The testis sections were stained with DAPI. 
Images were analyzed under a TCS SP8 
confocal laser-scanning microscope (Leica). 
  
In vitro fertilization assay 
Sperm were placed in l drop of TYH 
medium, covered with paraffin oil (Nacalai 
Tesque), and incubated at 37 °C for 2 h. Eight-
week-old C57BL/6 female mice were injected 
with 5 units of pregnant mare serum 
gonadotropin 62 h before in vitro fertilization 
(IVF) and with 5 units of human chorionic 
gonadotropin 14 h before IVF. Eggs were 
collected from the oviduct. In some cases, 
eggs were treated with 330 g/mL 


























collagenase (Sigma-Aldrich) at 37 °C for 10 
min to prepare cumulus-free or zona-free eggs, 
respectively. The eggs were placed in 1 drop 
of TYH medium. The eggs were incubated 
with 2.0 × 105 sperm for 6 h at 37 °C, washed 
with TYH medium, further incubated for 18 h, 
and observed under a Hoffman modulation 
contrast microscope (IX71; Olympus). 
 
Sperm motility assay  
To assess sperm motility, sperm in 
the TYH medium at 37 °C were allowed to 
swim out from the cauda epididymis for 10 
min or 120 min and were placed on standard 
count 2-chamber slides (Leja) (depth, 100 µm) 
that had been preheated to 37 °C. Sperm 
motility parameters (curvilinear velocity 
[VCL], straight-line velocity [VSL], and 
average path velocity [VAP]) were evaluated 
by a computer-assisted system (CEROS II 
sperm analysis system, software version 1.5.2; 
Hamilton Thorne Biosciences). 
 
Proteomics analysis   
Sperm isolated from PITHD1+/+ 
mice and PITHD1-/- mice in triplicate were 
lysed in 150 µL of 6 M guanidine-HCl 
containing 100 mM Tris-HCl, pH 8.0, and 2 
mM DTT. The lysates were dissolved by 
heating and sonication, followed by 
centrifugation at 20,000 × g for 15 min at 4 °C. 
The supernatants containing 100 µg protein 
each were reduced in 5 mM DTT at room 
temperature for 30 min and alkylated in 27.5 
mM iodoacetamide at room temperature for 
30 min in the dark. Proteins were purified by 
methanol/chloroform precipitation and 
solubilized with 25 µL of 0.1% RapiGest SF 
(Waters) in 50 mM triethylammonium 
bicarbonate buffer. After repeated sonication 
and vortexing, the proteins were digested with 
1 µg of trypsin/Lys-C mix (Promega) for 16 h 
at 37 °C. Peptide concentration was 
determined using Pierce Quantitative 
Colorimetric Peptide Assay (Thermo Fisher). 
Approximately 25 µg of peptides for each 
sample was labeled with 0.2 mg of TMT6plex 
reagents (Thermo Fisher) for 1 h at room 
temperature. After the reaction was quenched 
with hydroxylamine, all the TMT-labeled 
samples were pooled, acidified with 
trifluoroacetic acid (TFA), and fractionated 
using a Pierce High pH Reversed-phase 
Peptide Fractionation Kit (Thermo Fisher). 
Nine fractions were collected using 5%, 10%, 
12.5%, 15%, 17.5%, 20%, 22.5%, 25%, and 
50% acetonitrile (ACN) in 0.1% triethylamine. 
Each fraction was evaporated in a SpeedVac 
concentrator and dissolved in 0.1% TFA. 
LC-MS/MS analysis of the resultant 
peptides (1 µg each) was performed on an 
EASY-nLC 1200 UHPLC connected to a Q 
Exactive Plus mass spectrometer through a 
nanoelectrospray ion source (Thermo Fisher). 
The peptides were separated on a 75 µm inner 
diameter × 150 mm C18 reversed-phase 
column (Nikkyo Technos) with a linear 
gradient of 4–20% ACN for 0–180 min and 
20–32% ACN for 180–220 min, followed by 
an increase to 80% ACN for 220–230 min. 
The mass spectrometer was operated in the 
data-dependent acquisition mode with a top 15 
MS/MS method. MS1 spectra were measured 
at the resolution of 70,000, the automatic gain 
control (AGC) target of 3 × 106, and a mass 
range of 375 to 1,400 m/z. HCD MS/MS 
spectra were acquired at the resolution of 
35,000, the AGC target of 1 × 105, the 
isolation window of 0.4 m/z, the maximum 
injection time of 100 msec, and the 
normalized collision energy of 32. Dynamic 
exclusion was set to 30 sec. Raw data were 
directly analyzed against Swiss-Prot database 
version 2017-10-25 restricted to Mus 
musculus (25,097 sequences) using Proteome 
Discoverer version 2.2 (Thermo Fisher) with 
Mascot search engine version 2.5 (Matrix 
Science) for identification and TMT 
quantification. The search parameters were (a) 
trypsin as an enzyme with up to two missed 
cleavages, (b) precursor mass tolerance of 10 
ppm, (c) fragment mass tolerance of 0.02 Da, 
(d) TMT of lysine and peptide N-terminus and 
carbamidomethylation of cysteine as fixed 
modifications, and (e) acetylation of protein 
N-terminus and oxidation of methionine as 
variable modifications. Quantification was 
performed by using the Reporter Ion 
Quantification node of the Proteome 
Discoverer software. Peptides and proteins 


























of 1% using the percolator node and the 
protein FDR validator node, respectively. 
 
Statistical analysis  
Statistical significance was assessed 
using the two-tailed unpaired Student’s t test 
with Welch’s correction for unequal variances. 
Q value was calculated using the multiple 
unpaired t test with the false discovery rate 
approach (48). The data are presented as 




MS proteomics data have been 
deposited to the ProteomeXchange 
Consortium via jPOST partner repository 
(https://repository.jpostdb.org) with the 
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Figure 1. Association capability of PITHD1 with proteasomes in thymus and testis   
(A) Relative mRNA expression of Pithd1 in indicated cells and organs isolated from 2-week-old 
C57BL/6 mice. The expression levels (means ± SEMs) of Pithd1 measured by quantitative RT-
PCR were normalized to that of Gapdh and compared with the level measured in thymocytes. 
*P<0.05, n.s., not significant. Plotted are the results of three independent experiments using 
samples obtained from three to nine mice. 
(B, C) Thymus lysates were immunoprecipitated with anti-b5t antibody (B), anti-a6 antibody (C), 
or control IgG followed by immunoblotting with anti-PITHD1, anti-b5t, and anti-a6 antibodies.  
(D-F) Testis lysates were immunoprecipitated with anti-a4s antibody (D), anti-b5i antibody (E), 
anti-a6 antibody (F), or control IgG followed by immunoblotting with anti-PITHD1, anti-a4s, 
anti-β5i, and anti-α6 antibodies. 
(G, H) Thymus lysates from b5t-deficient (G) or b5t-sufficient (H) mice were 
immunoprecipitated with anti-b5i antibody or control IgG followed by immunoblotting with anti-
PITHD1, anti-b5i, and anti-a6 antibodies. 
Red arrowheads indicate each protein. Black arrowheads indicate IgG light chain. All images in 




























































Figure 2. Generation of PITHD1-deficient mice 
(A) Schematic diagram of Pithd1 locus, targeting vector, and targeted allele. DT-A, diphtheria 
toxin A. pgk-Neo-pA, phosphoglycerate kinase I promoter-driven neomycin resistance gene 
followed by polyadenylation signal sequence. 3’ probe is for Southern blot analysis. Arrows 
indicate primers for genotyping PCR.  
(B) Genotyping PCR analysis of genomic DNA from indicated mice. Gel electrophoresis of 
amplified wild-type allele fragment (763 bp) and targeted allele fragment (1058 bp). Positions of 
the primers are shown in (A). WT, PITHD1+/+ mice. Het, PITHD1+/- mice. KO, PITHD1-/- 
mice. 
(C) Southern blot analysis of BamHI-digested genomic DNA from indicated mice. Probe is 
shown in (A). Signals at 5.4 kbp and 9 kbp indicate wild-type and targeted alleles, respectively.  
(D) Relative mRNA expression of Pithd1 in thymus and testis isolated from 4-week-old mice. 
The expression levels (means ± SEMs) of Pithd1 measured by quantitative RT-PCR were 
normalized to that of Gapdh. ***P<0.001. Plotted are the results of three independent 
experiments using the samples obtained from three mice per group. 
(E) Immunoblot analysis of PITHD1 protein in thymus and testis isolated from 4-week-old mice. 
β-Actin was examined as loading control.  
(F) Immunofluorescence analysis of tdTomato (red), Ly51 (green), and UEA1 (blue) in thymic 
section of PITHD1+/- (PITHD1+/tdTomato) mice. Bar, 100 µm.  


























(H) Immunofluorescence analysis of tdTomato (red) and DAPI (blue) in testis section. Bar, 100 
µm.  
(I) Detection of tdTomato fluorescence in testicular cells analyzed by flow cytometry. 
(J) Immunofluorescence analysis of tdTomato (red) and DAPI (gray) in indicated cells isolated 
from PITHD1+/- (PITHD1+/tdTomato) mice at 8-week-old. Scale bars, 20 µm. 
All images (B, C, E, F, H, and J) and histograms (G and I) are representative results of at least 








































































Figure 3. Characterization of the thymus in PITHD1-deficient mice 
(A) Hematoxylin and eosin staining of thymic sections from 4-week-old mice. Representative 
data from three independent mice analyzed in three independent experiments are shown. Scale 
bar, 500 µm. 
(B) Immunofluorescence analysis of b5t (green), Aire (red), and UEA-1-binding molecules (blue) 
in thymic sections from 4-week-old mice. Representative data from three independent mice 


























(C) Flow cytometric analysis of liberase-digested thymic cells isolated from 4-week-old mice. 
Shown are dot plots of EpCAM and CD45 expression in total cells (left) and UEA1 reactivity and 
Ly51 expression in CD45-EpCAM+-gated epithelial cells (right). Plots on the right show cell 
number (means ± SEMs) of CD45-EpCAM+UEA1-Ly51+ cTECs and CD45-
EpCAM+UEA1+Ly51- mTECs in individual mice, measured in six independent experiments.  
(D) Histograms show the detection of proteasome activity by cell-permeable triple-leucine 
substrate-based fluorescent probe in cTECs and mTECs of PITHD1+/+ mice (blue line) and 
PITHD1-/- mice (red line). Shaded area and black line represent background fluorescence profiles 
without the addition of proteasome probe in PITHD1+/+ TECs and PITHD1-/- TECs, respectively. 
Plots on the right show mean fluorescence intensity (means ± SEMs) of indicated cells in 
individual mice, measured in three independent experiments.  
(E) Flow cytometric analysis of total thymocytes isolated from 4-week-old mice. Shown are dot 
plots of CD4 and CD8 expression in propidium iodide- (PI-) thymocytes. Plots on the right show 
cell number (means ± SEMs) of indicated cell populations in individual mice, measured in five 
independent experiments. 
(F) Flow cytometric analysis of CD44 and CD25 expression in CD4-CD8- thymocytes. Plots on 
the right show cell number (means ± SEMs) of CD44+CD25- cells (DN1), CD44+CD25+ cells 
(DN2), CD44-CD25+ cells (DN3), and CD44-CD25- cells (DN4) in individual mice, measured 
in five independent experiments.   
(G) Flow cytometric analysis of CD69 and TCRb expression in CD4+CD8+ thymocytes. Plots 
on the right show cell number (means ± SEMs) of CD69+TCRb-/low cells (population I), 
CD69+TCRblow cells (population II), and CD69+TCRbhigh cells (population III) in individual 
mice, measured in three independent experiments.  
(H) Flow cytometric analysis of spleen cells. Shown are dot plots of CD4 and CD8 expression in 
CD3+ splenic T cells. Plots on the right show cell number (means ± SEMs) of indicated cell 
populations in individual mice, measured in five independent experiments. 




























































Figure 4. T cell development in b5t/PITHD1-double-deficient mice 
(A) Flow cytometric analysis of liberase-digested thymic cells from indicated mice. Shown are 
dot plots of UEA1 reactivity and Ly51 expression in CD45-EpCAM+-gated epithelial cells. Plots 
on the right show cell number (means ± SEMs) of CD45-EpCAM+UEA1-Ly51+ cTECs and 
CD45-EpCAM+UEA1+Ly51- mTECs in individual mice, measured in three independent 
experiments. 
(B) Flow cytometric analysis of total thymocytes. Shown are dot plots of CD4 and CD8 
expression in PI-TCRhigh thymocytes. Plots on the right show cell number (means ± SEMs) of 
indicated cell populations in individual mice, measured in three independent experiments. 
(C) Flow cytometric analysis of spleen cells. Shown are dot plots of CD4 and CD8 expression in 
CD3+ splenic T cells. Plots on the right show cell number (means ± SEMs) of indicated cell 
populations in individual mice, measured in three independent experiments. 




























































Figure 5. Male infertility in PITHD1-deficient mice 
(A) Weights (means ± SEMs, individually measured for four mice) of testis and epididymis in 8-
week-old mice. n.s., not significant. 
(B) Hematoxylin and eosin staining of testis and epididymis sections from 8-week-old mice. 
Representative data from three independent mice analyzed in three independent experiments are 
shown. Scale bar, 100 µm. 
(C) Four PITHD1+/- male mice and four PITHD1-/- male mice were mated with C57BL/6 female 
mice, respectively. Plots on the left show pregnancy rate (pregnancy/vaginal plug formation) in 
female mice mated with indicated male mice. Plots on the right show the number of pups born in 
one pregnancy. Means ± SEMs are shown by black bars.  
(D) In vitro fertilization assay. Sperm from indicated male mice were incubated with cumulus-
intact, cumulus-free, or zona-free wild-type eggs, and the numbers of eggs carrying pronuclei 
(zona-free eggs; n = 176) and of eggs that had reached the 2-cell stage (cumulus-intact eggs; n = 
521, cumulus-free eggs; n = 247) were counted. The frequencies (means ± SEMs) of fertilized 









































































Figure 6. Generation of PITHD1-deletion mice by CRISPR/Cas9 technology 
(A) Schematic diagram of Pithd1 locus and targeted allele. Bold arrows indicate the position of 
guide RNA. Primer 1, primer 2, and primer 3 are for genotyping PCR. 
(B) Genotyping PCR analysis of genomic DNA from indicated mice. Gel electrophoresis of 


























the primers are shown in (A). Representative data from three independent mice analyzed in three 
independent experiments are shown. 
(C) Relative mRNA expression of Pithd1 in testis. The expression levels (means ± SEMs) of 
Pithd1 measured by quantitative RT-PCR were normalized to that of Gapdh. *P<0.05. Plotted 
are the results of three independent experiments using three mice per group. 
(D) Immunoblot analysis of PITHD1 protein in testis isolated from 8-week-old mice. β-Actin was 
examined as loading control. Representative results of three independent experiments. 
(E) Flow cytometric analysis of liberase-digested thymic cells isolated from 8-week-old mice. 
Shown are dot plots of EpCAM and CD45 expression in total cells (left) and UEA1 reactivity and 
Ly51 expression in CD45-EpCAM+ epithelial cells (right). Plots on the right show cell number 
(means ± SEMs) of CD45-EpCAM+UEA1-Ly51+ cTECs and CD45-EpCAM+UEA1+Ly51- 
mTECs in individual mice, measured in three independent experiments.  
(F) Flow cytometric analysis of total thymocytes isolated from 8-week-old mice. Shown are dot 
plots of CD4 and CD8 expression in propidium iodide- (PI-) thymocytes. Plots on the right show 
cell number (means ± SEMs) of indicated cell populations in individual mice, measured in three 
independent experiments.  
(G) Flow cytometric analysis of total spleen cells isolated from 8-week-old mice. Shown are dot 
plots of CD4 and CD8 expression in CD3+ splenic T cells. Plots on the right show cell number 
(means ± SEMs) of indicated cell populations in individual mice, measured in three independent 
experiments.  
Numbers in dot plots indicate frequency of cells within indicated area. n.s., not significant. 
(H) Hematoxylin and eosin staining of testis and epididymis sections from 8-week-old mice. 
Representative data from three independent experiments are shown. Scale bar, 100 µm. 
(I) In vitro fertilization assay. Sperm from indicated male mice were incubated with cumulus-
intact, cumulus-free, or zona-free wild-type eggs, and the numbers of eggs carrying pronuclei 
(zona-free eggs; n = 177) and of eggs that had reached the 2-cell stage (cumulus-intact eggs, n = 
101; cumulus-free eggs; n = 38) were counted. The frequencies (means ± SEMs) of fertilized eggs 






























































Figure 7. Morphological abnormalities and impaired motility of PITHD1-deficient sperm  
(A) Morphology of sperm isolated from PITHD1-/- mice. All images are representative results of 
three independent mice in three independent experiments. 
(B, C) Frequency (means ± SEMs) of sperm exhibiting indicated morphologies, measured 
individually in PITHD1-/- mice (B), PITHD1D/D mice (C), and control mice (three mice per 
group). *P< 0.05, **P< 0.01, ***P< 0.001, n.s., not significant.  
(D, E) Sperm isolated from PITHD1-/- mice (D), PITHD1D/D mice (E), and control mice were 
allowed to swim out from the dissected cauda epididymis in TYH medium for 10 min 
(noncapacitating) or 2 h (capacitating). Average path velocity (VAP), curvilinear velocity (VCL), 
and straight-line velocity (VSL) were measured using a computer-assisted sperm analysis system. 
Shown are graphs of each parameter (means ± SEMs) measured in sperm isolated individually 
from three to four mice per group. *P< 0.05, **P< 0.01, ***P< 0.001, n.s., not significant.  
(F, G) Frequencies of indicated morphologies observed in motile sperm isolated from PITHD1-
/- mice (F), PITHD1D/D mice (G), and control mice. n, sperm number measured in individual 

























































Figure 8. Alteration of proteasome activity in testicular cells by PITHD1 deficiency 
(A) Histograms show the detection of proteasome activity by cell-permeable triple-leucine 
substrate-based fluorescent probe in testicular cells and sperm of PITHD1+/- mice (blue line) and 
PITHD1-/- mice (red line). Shaded area and black line represent background fluorescence profiles 
without the addition of proteasome probe in PITHD1+/- mice and PITHD1-/- mice, respectively. 
Representative data from four to five independent mice measured in four independent 
experiments are shown. 
(B) Mean fluorescence intensity (means ± SEMs) of triple-leucine substrate-based fluorescent 
probe in indicated cells in PITHD1+/- mice (blue symbols) and PITHD1-/- mice (red symbols) 
from four independent experiments. *P<0.05. 
(C) Immunoblot analysis of PITHD1 protein in testis and sperm isolated from cauda epididymis 
and caput epididymis of PITHD1+/+ mice. β-Actin was examined as loading control. 
Representative results of four independent experiments are shown. Graph shows the intensity 
(means ± SEMs) of PITHD1 signal detected by immunoblotting relative to β-Actin signal. 
*P<0.05, **P<0.01. 
(D) Volcano plot analysis of proteomes for sperm isolated from PITHD1+/+ mice and PITHD1-
/- mice (three mice per group) at 8-week-old. Detected proteins are plotted as log2 fold changes 
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